Molecular AF
- Product NDC
- 76348-401
- 11-digit product format
- 763480401
- Labeler code
- 76348
- Product ID
- 76348-401_2d3f2f5e-be56-71e9-e063-6294a90a6ac2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- tolnaftate
- Dosage form
- OIL
- Route
- TOPICAL
- Labeler
- Renu Laboratories, LLC
- Application
- M005
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-07-01
- Substance
- TOLNAFTATE
- Active strength
- .01 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Molecular AF
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOLNAFTATE | .01 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 06KB629TKV | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 76348-401-01 | 2025-02-04 | MOLECULAR AF |
| 76348-401-02 | 2025-02-04 | MOLECULAR AF |
| 76348-401-01 | 2025-01-30 | MOLECULAR AF |
| 76348-401-02 | 2025-01-30 | MOLECULAR AF |
| 76348-401-01 | 2023-06-13 | MOLECULAR AF |
| 76348-401-02 | 2023-06-13 | MOLECULAR AF |
| 76348-401-01 | 2020-01-31 | MOLECULAR AF |
| 76348-401-02 | 2020-01-31 | MOLECULAR AF |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-401-01 | Molecular AF | 11.5 mL in 1 BOTTLE | OIL | 11.5 | 4 | |
| 76348-401-02 | Molecular AF | 11.5 mL in 1 BOX | OIL | 11.5 | 4 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TOLNAFTATE | ACTIVE INGREDIENT | 06KB629TKV | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| TOLNAFTATE | ACTIVE MOIETY | 06KB629TKV | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| CINNAMON OIL | INACTIVE INGREDIENT | E5GY4I6YCZ | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| ETHYL MACADAMIATE | INACTIVE INGREDIENT | ANA2NCS6V1 | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| OLIVE OIL | INACTIVE INGREDIENT | 6UYK2W1W1E | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole | CLOTRIMAZOLE | AvPAK | 3ca3b475-7b69-442a-e063-6294a90a7b3f | 2025-08-18 | Warnings | M005 |
| Formula 3 | TOLNAFTATE | The Tetra Corporation | 0895274b-a09d-4264-a43f-852e44eb3163 | 2025-08-18 | Warnings | M005 |
| Formula 7 - The Solution | TOLNAFTATE | The Tetra Corporation | 18619649-7f79-4b6e-8b7c-69d70365d557 | 2025-08-18 | Warnings | M005 |
| GlyCylic | SALICYLIC ACID | The Tetra Corporation | 501d3ba9-ba42-4c1c-983b-492adaee039d | 2025-08-18 | Warnings | M005 |
| SupreH Ringworm Treatment Balm | SUPREH RINGWORM TREATMENT BALM | Shenzhen Xinxin Yunhai Technology Co., Ltd. | 3c77222b-d92e-84b0-e063-6294a90aadd7 | 2025-08-16 | Warnings | M005 |
| OetMoe Antifungal Solution | OETMOE ANTIFUNGAL SOLUTION | Shenzhen Earth Surface Trading Co., Ltd. | 3c26d917-4186-6f02-e063-6394a90a99f6 | 2025-08-12 | Warnings | M005 |
| Cureforte Anti Fungal Foot Care | ANTI FUNGAL FOOT CARE DROPS | STEEL CITY HEALTH PRIVATE LIMITED | 39f762a6-9d0c-8ded-e063-6394a90a3659 | 2025-08-11 | Warnings | M005 |
| Derman Antifungal Powder Tolnaftate | TOLNAFTATE | Taisho Pharmaceutical California Inc. | 3a854765-740c-4719-8abf-4b3f932cdee0 | 2025-08-07 | Warnings | M005 |
| Derman antifungal cream | TOLNAFTATE | Taisho Pharmaceutical California Inc. | 15d9b3c9-01af-4083-a1bc-014505d8798d | 2025-08-07 | Warnings | M005 |
| Maximum Strength Antifungal Liquid | TOLNAFTATE | Hudson Health LLC | 24b22794-f9f8-6f32-e063-6394a90aec98 | 2025-08-07 | Warnings | M005 |
| Toe Area Treatment | TOLNAFTATE | CVS | 17681cc8-fbb1-a0cf-e063-6294a90add18 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Family Dollar Services, Inc | 178e7b3f-949f-3f51-e063-6294a90a9395 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | LEADER/Cardinal Health 110, Inc. | 17695563-3765-74cb-e063-6294a90a6120 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Target Corporation | 1dff278f-47bc-459a-e063-6394a90a2646 | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | TopCo Associates | 19c268a1-7b2e-63c9-e063-6394a90acddc | 2025-08-07 | Warnings | M005 |
| Antifungal Liquid Maximum Strength | TOLNAFTATE | Walgreens Company | 137eabb7-cb4f-1631-e063-6294a90ab847 | 2025-08-07 | Warnings | M005 |
| WCTNGO Fungal Nail Treatment Swabs | TOLNAFTATE,UNDECYLENIC ACID | Shenzhen Boyimei Technology Co., Ltd. | 3bad0d73-b33d-b962-e063-6294a90a7ba7 | 2025-08-06 | Warnings | M005 |
| ONIADBA Nail Fungus Treatment Pen | TOLNAFTATE,UNDECYLENIC ACID | Shenzhen Boyimei Technology Co., Ltd. | 3bad19f1-d5b3-c5de-e063-6294a90a0c03 | 2025-08-06 | Warnings | M005 |
| Antifungal Liquid | TOLNAFTATE | Premier Brands of America Inc | 2644ba07-aaee-6402-e063-6394a90a2827 | 2025-08-06 | Warnings | M005 |
| Anti- Fungal Miconazole Nitrate | MICONAZOLE NITRATE | Premier Brands of America Inc. | f186bdc1-db6c-0fab-e053-2995a90a7c58 | 2025-08-06 | Warnings | M005 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1362942 | Molecular AF 1 % Antifungal Topical Oil | PSN | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 1 % Topical Oil | PSN | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | tolnaftate 10 MG/ML Topical Oil [Molecular AF] | SBD | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 10 MG/ML Topical Oil | SCD | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | Molecular AF 1 % Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | Molecular AF 10 MG/ML Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 1 % Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76348-401-01 | 76348040101 | 11.5 mL in 1 BOTTLE (76348-401-01) | 11.5 ml | 2011-07-01 | No | No | Current |
| 76348-401-02 | 76348040102 | 11.5 mL in 1 BOX (76348-401-02) | 11.5 ml | 2011-07-01 | No | No | Current |